Experimental group:Cladribine+Cytarabine+Granulocyte colony-stimulating factor+Mitoxantrone liposome

2 trials

Sponsors

The Second Affiliated Hospital of the Army Medical University of the PLA

Conditions

Relapsed or Refractory Acute Myeloid Leukemia

Phase 4

Dose-escalation clinical study of mitoxantrone hydrochloride liposome injection combined with cladribine, cytarabine and granulocyte colony-stimulating factor in the treatment of relapsed or refractory acute myeloid leukemia

RecruitingChiCTR2200060080

The Second Affiliated Hospital of the Army Medical University of the PLARelapsed or Refractory Acute Myeloid Leukemia

Start: 2022-05-18Updated: 2024-04-22

A prospective, multi-center clinical study of mitoxantrone hydrochloride liposome injection combined with cladribine, cytarabine and granulocyte colony-stimulating factor in the treatment of relapsed and refractory acute myeloid leukemia

Active, not recruitingChiCTR2400086291

The Second Affiliated Hospital of the Army Medical University of the PLARelapsed or Refractory Acute Myeloid Leukemia

Start: 2024-07-01Updated: 2024-07-08

Related Papers

Combination of mitoxantrone hydrochloride liposome with CLAG regimen in patients with relapsed or refractory Acute Myeloid Leukemia: A prospective, single-arm study

Blood2025-11-03